Formononetin alleviates ovarian fibrosis and inflammation via targeting SOCS3 and inhibiting TGF-β1/Smad signaling in PCOSOA
Formononetin alleviates ovarian fibrosis and inflammation via targeting SOCS3 and inhibiting TGF-β1/Smad signaling in PCOS
Aifen Liu;Lei Zhang;Jingyan Hu;Weili Yu;Chuanyu Cang;Chuanjing Shi;Xi Wang;Rui Wang;Xuanwei Cai;Fengbo Zhao
Basic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,China||Department of Pharmaceutical Botany,School of Pharmacy,Naval Medical University,Shanghai 200433,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,ChinaBasic Medical Research Centre,School of Medicine,Nantong University,Nantong 226001,China
formononetininflammationovarian fibrosisPCOSSOCS3TGF-β1/Smad
formononetininflammationovarian fibrosisPCOSSOCS3TGF-β1/Smad
《中草药（英文版）》 2026 (3)
604-620,17
This work was financially supported by the Xinjiang Special Program for Supporting Talent in Critical Fields(No.XJRC-2025-ZZB-ZDXQ-014),the National Key Research and Development Pro-gram of China(No.2024YFC3506400),National Natural Science Foundation of China(No.82225047),the High-level Talents Pro-gram of Nantong University,and Postgraduate Research & Practice Innovation Program of Jiangsu Province(No.KYCX24_3569).
评论